View in EDS

Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis.

Saved in:
Bibliographic Details
Title: Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis.
Authors: Koether K; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Besnard V; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France., Sandig H; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Carruthers A; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Miranda E; Imaging and AI, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK., Grootenboer-Mignot S; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Laboratoire d'Immunologie 'Autoimmunité et Hypersensibilités', Paris, France., Taillé C; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Service de Pneumologie, FHU APOLLO, 75018, Paris, France., Chevret S; Biostatistics and Clinical Epidemiology team, INSERM UMR 1153, Université de Paris, SBIM- Hôpital Saint Louis, Paris, France., Valeyre D; AP-HP, Hôpital Avicenne, Service de Pneumologie, UMR Inserm 1272, Université Paris Nord, Bobigny, France., Nunes H; AP-HP, Hôpital Avicenne, Service de Pneumologie, UMR Inserm 1272, Université Paris Nord, Bobigny, France., Israel-Biet D; AP-HP, Hôpital Européen Georges Pompidou, Service de Pneumologie, Université de Paris, Paris, France., Lim WK; Regeneron Pharmaceuticals, Tarrytown, NY, USA., Cottin V; Hospices Civils de Lyon, Hôpital Louis Pradel, Université Claude Bernard Lyon 1, Lyon, France., Corkill D; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Dobson C; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK., Groves M; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK., Ferraro F; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK., Guenzi E; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Département d'Anatomopathologie, Paris, France., Huang L; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Sulikowski M; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Mailleux A; AP-HP, Hôpital Bichat, Laboratoire d'Immunologie 'Autoimmunité et Hypersensibilités', Paris, France., Murray LA; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK., Mustelin T; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA, USA., Strickland I; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript., Sleeman MA; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript., Crestani B; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France bruno.crestani@aphp.fr.; AP-HP, Hôpital Bichat, Service de Pneumologie, FHU APOLLO, 75018, Paris, France.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript.
Source: The European respiratory journal [Eur Respir J] 2023 May 18; Vol. 61 (5). Date of Electronic Publication: 2023 May 18 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37080573
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Koether+K%22">Koether K</searchLink>; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Besnard+V%22">Besnard V</searchLink>; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sandig+H%22">Sandig H</searchLink>; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Carruthers+A%22">Carruthers A</searchLink>; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Miranda+E%22">Miranda E</searchLink>; Imaging and AI, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Grootenboer-Mignot+S%22">Grootenboer-Mignot S</searchLink>; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Laboratoire d'Immunologie 'Autoimmunité et Hypersensibilités', Paris, France.<br /><searchLink fieldCode="AU" term="%22Taillé+C%22">Taillé C</searchLink>; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Service de Pneumologie, FHU APOLLO, 75018, Paris, France.<br /><searchLink fieldCode="AU" term="%22Chevret+S%22">Chevret S</searchLink>; Biostatistics and Clinical Epidemiology team, INSERM UMR 1153, Université de Paris, SBIM- Hôpital Saint Louis, Paris, France.<br /><searchLink fieldCode="AU" term="%22Valeyre+D%22">Valeyre D</searchLink>; AP-HP, Hôpital Avicenne, Service de Pneumologie, UMR Inserm 1272, Université Paris Nord, Bobigny, France.<br /><searchLink fieldCode="AU" term="%22Nunes+H%22">Nunes H</searchLink>; AP-HP, Hôpital Avicenne, Service de Pneumologie, UMR Inserm 1272, Université Paris Nord, Bobigny, France.<br /><searchLink fieldCode="AU" term="%22Israel-Biet+D%22">Israel-Biet D</searchLink>; AP-HP, Hôpital Européen Georges Pompidou, Service de Pneumologie, Université de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lim+WK%22">Lim WK</searchLink>; Regeneron Pharmaceuticals, Tarrytown, NY, USA.<br /><searchLink fieldCode="AU" term="%22Cottin+V%22">Cottin V</searchLink>; Hospices Civils de Lyon, Hôpital Louis Pradel, Université Claude Bernard Lyon 1, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Corkill+D%22">Corkill D</searchLink>; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Dobson+C%22">Dobson C</searchLink>; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Groves+M%22">Groves M</searchLink>; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Ferraro+F%22">Ferraro F</searchLink>; Antibody Discovery and Protein Engineering, R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Guenzi+E%22">Guenzi E</searchLink>; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France.; AP-HP, Hôpital Bichat, Département d'Anatomopathologie, Paris, France.<br /><searchLink fieldCode="AU" term="%22Huang+L%22">Huang L</searchLink>; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Sulikowski+M%22">Sulikowski M</searchLink>; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Mailleux+A%22">Mailleux A</searchLink>; AP-HP, Hôpital Bichat, Laboratoire d'Immunologie 'Autoimmunité et Hypersensibilités', Paris, France.<br /><searchLink fieldCode="AU" term="%22Murray+LA%22">Murray LA</searchLink>; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Mustelin+T%22">Mustelin T</searchLink>; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA, USA.<br /><searchLink fieldCode="AU" term="%22Strickland+I%22">Strickland I</searchLink>; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript.<br /><searchLink fieldCode="AU" term="%22Sleeman+MA%22">Sleeman MA</searchLink>; Bioscience, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript.<br /><searchLink fieldCode="AU" term="%22Crestani+B%22">Crestani B</searchLink>; INSERM U1152, Université Paris Cité, Labex Inflamex, 75018, Paris, France bruno.crestani@aphp.fr.; AP-HP, Hôpital Bichat, Service de Pneumologie, FHU APOLLO, 75018, Paris, France.; I. Strickland, M.A. Sleeman and B. Crestani contributed equally to this manuscript.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228803460%22">The European respiratory journal</searchLink> [Eur Respir J] 2023 May 18; Vol. 61 (5). <i>Date of Electronic Publication: </i>2023 May 18 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22European+Respiratory+Society%22">European Respiratory Society </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8803460 <i>Publication Model: </i>Electronic-Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1399-3003 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209031936%22">09031936 </searchLink><i>NLM ISO Abbreviation: </i>Eur Respir J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37080573
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1183/13993003.02381-2021
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Autoantibodies are associated with disease progression in idiopathic pulmonary fibrosis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Koether K
      – PersonEntity:
          Name:
            NameFull: Besnard V
      – PersonEntity:
          Name:
            NameFull: Sandig H
      – PersonEntity:
          Name:
            NameFull: Carruthers A
      – PersonEntity:
          Name:
            NameFull: Miranda E
      – PersonEntity:
          Name:
            NameFull: Grootenboer-Mignot S
      – PersonEntity:
          Name:
            NameFull: Taillé C
      – PersonEntity:
          Name:
            NameFull: Chevret S
      – PersonEntity:
          Name:
            NameFull: Valeyre D
      – PersonEntity:
          Name:
            NameFull: Nunes H
      – PersonEntity:
          Name:
            NameFull: Israel-Biet D
      – PersonEntity:
          Name:
            NameFull: Lim WK
      – PersonEntity:
          Name:
            NameFull: Cottin V
      – PersonEntity:
          Name:
            NameFull: Corkill D
      – PersonEntity:
          Name:
            NameFull: Dobson C
      – PersonEntity:
          Name:
            NameFull: Groves M
      – PersonEntity:
          Name:
            NameFull: Ferraro F
      – PersonEntity:
          Name:
            NameFull: Guenzi E
      – PersonEntity:
          Name:
            NameFull: Huang L
      – PersonEntity:
          Name:
            NameFull: Sulikowski M
      – PersonEntity:
          Name:
            NameFull: Mailleux A
      – PersonEntity:
          Name:
            NameFull: Murray LA
      – PersonEntity:
          Name:
            NameFull: Mustelin T
      – PersonEntity:
          Name:
            NameFull: Strickland I
      – PersonEntity:
          Name:
            NameFull: Sleeman MA
      – PersonEntity:
          Name:
            NameFull: Crestani B
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 05
              Text: 2023 May 18
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1399-3003
          Numbering:
            – Type: volume
              Value: 61
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: The European respiratory journal
              Type: main
ResultId 1